Literature DB >> 29768667

Analyzing self-controlled case series data when case confirmation rates are estimated from an internal validation sample.

Stanley Xu1,2, Christina L Clarke1, Sophia R Newcomer1,2, Matthew F Daley1,3, Jason M Glanz1,2.   

Abstract

Vaccine safety studies are often electronic health record (EHR)-based observational studies. These studies often face significant methodological challenges, including confounding and misclassification of adverse event. Vaccine safety researchers use self-controlled case series (SCCS) study design to handle confounding effect and employ medical chart review to ascertain cases that are identified using EHR data. However, for common adverse events, limited resources often make it impossible to adjudicate all adverse events observed in electronic data. In this paper, we considered four approaches for analyzing SCCS data with confirmation rates estimated from an internal validation sample: (1) observed cases, (2) confirmed cases only, (3) known confirmation rate, and (4) multiple imputation (MI). We conducted a simulation study to evaluate these four approaches using type I error rates, percent bias, and empirical power. Our simulation results suggest that when misclassification of adverse events is present, approaches such as observed cases, confirmed case only, and known confirmation rate may inflate the type I error, yield biased point estimates, and affect statistical power. The multiple imputation approach considers the uncertainty of estimated confirmation rates from an internal validation sample, yields a proper type I error rate, largely unbiased point estimate, proper variance estimate, and statistical power.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  confirmation rate of cases; internal validation sample; multiple imputation; self-controlled case series; vaccine safety

Mesh:

Substances:

Year:  2018        PMID: 29768667      PMCID: PMC6589832          DOI: 10.1002/bimj.201700088

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  28 in total

1.  Multiple-imputation for measurement-error correction.

Authors:  Stephen R Cole; Haitao Chu; Sander Greenland
Journal:  Int J Epidemiol       Date:  2006-05-18       Impact factor: 7.196

2.  Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper.

Authors:  Charles Safran; Meryl Bloomrosen; W Edward Hammond; Steven Labkoff; Suzanne Markel-Fox; Paul C Tang; Don E Detmer
Journal:  J Am Med Inform Assoc       Date:  2006-10-31       Impact factor: 4.497

3.  The new Sentinel Network--improving the evidence of medical-product safety.

Authors:  Richard Platt; Marcus Wilson; K Arnold Chan; Joshua S Benner; Janet Marchibroda; Mark McClellan
Journal:  N Engl J Med       Date:  2009-07-27       Impact factor: 91.245

4.  Adding value to the electronic health record through secondary use of data for quality assurance, research, and surveillance.

Authors:  William R Hersh
Journal:  Am J Manag Care       Date:  2007-06       Impact factor: 2.229

5.  Identifying optimal risk windows for self-controlled case series studies of vaccine safety.

Authors:  Stanley Xu; Lijing Zhang; Jennifer C Nelson; Chan Zeng; John Mullooly; David McClure; Jason Glanz
Journal:  Stat Med       Date:  2010-11-30       Impact factor: 2.373

6.  Validation data-based adjustments for outcome misclassification in logistic regression: an illustration.

Authors:  Robert H Lyles; Li Tang; Hillary M Superak; Caroline C King; David D Celentano; Yungtai Lo; Jack D Sobel
Journal:  Epidemiology       Date:  2011-07       Impact factor: 4.822

7.  Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Authors:  Simon J Hambidge; Jason M Glanz; Eric K France; David McClure; Stanley Xu; Kristi Yamasaki; Lisa Jackson; John P Mullooly; Kenneth M Zangwill; S Michael Marcy; Steven B Black; Edwin M Lewis; Henry R Shinefield; Edward Belongia; James Nordin; Robert T Chen; David K Shay; Robert L Davis; Frank DeStefano
Journal:  JAMA       Date:  2006-10-25       Impact factor: 56.272

8.  Idiopathic thrombocytopenic purpura and MMR vaccine.

Authors:  E Miller; P Waight; C P Farrington; N Andrews; J Stowe; B Taylor
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

9.  Predictive value of ICD-9-CM codes used in vaccine safety research.

Authors:  J P Mullooly; J G Donahue; F DeStefano; J Baggs; E Eriksen
Journal:  Methods Inf Med       Date:  2008       Impact factor: 2.176

10.  Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety.

Authors:  J Mullooly; L Drew; F DeStefano; J Maher; K Bohlke; V Immanuel; S Black; E Lewis; P Ray; C Vadheim; M Lugg; R Chen
Journal:  Methods Inf Med       Date:  2004       Impact factor: 2.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.